| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
544 |
516 |
$82K |
| 71046 |
Radiologic examination, chest; 2 views |
1,945 |
1,792 |
$63K |
| 80053 |
Comprehensive metabolic panel |
6,259 |
5,327 |
$39K |
| 76830 |
Ultrasound, transvaginal |
397 |
384 |
$35K |
| 36415 |
Collection of venous blood by venipuncture |
10,134 |
8,973 |
$31K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,210 |
6,785 |
$29K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,441 |
1,290 |
$24K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
426 |
411 |
$21K |
| 83690 |
|
2,976 |
2,754 |
$17K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
191 |
182 |
$17K |
| 84484 |
|
1,902 |
1,530 |
$13K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
299 |
299 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,783 |
1,547 |
$11K |
| 71045 |
Radiologic examination, chest; single view |
344 |
322 |
$10K |
| 87210 |
|
1,691 |
1,565 |
$9K |
| 80178 |
|
693 |
632 |
$8K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
385 |
385 |
$8K |
| 81001 |
|
3,584 |
3,254 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,099 |
1,012 |
$6K |
| 86140 |
|
1,280 |
1,076 |
$6K |
| 81025 |
|
3,146 |
2,808 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
232 |
228 |
$4K |
| 80305 |
|
483 |
431 |
$3K |
| 85610 |
|
1,361 |
1,080 |
$3K |
| 81003 |
|
1,828 |
1,676 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
21 |
13 |
$3K |
| 85379 |
|
425 |
399 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
119 |
113 |
$2K |
| 83880 |
|
119 |
107 |
$1K |
| 73630 |
|
43 |
37 |
$1K |
| 76536 |
|
16 |
16 |
$1K |
| 82565 |
|
220 |
186 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
14 |
13 |
$923.62 |
| 76642 |
|
14 |
12 |
$912.34 |
| 83605 |
|
117 |
93 |
$907.67 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,628 |
1,536 |
$379.77 |
| 86850 |
|
70 |
65 |
$365.06 |
| 86901 |
|
169 |
158 |
$353.91 |
| 86900 |
|
87 |
82 |
$321.63 |
| 84702 |
|
35 |
28 |
$297.03 |
| 83735 |
|
104 |
80 |
$290.87 |
| 93971 |
|
12 |
12 |
$275.98 |
| 85027 |
|
30 |
27 |
$137.33 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14 |
13 |
$119.76 |
| 84132 |
|
15 |
12 |
$32.13 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
51 |
45 |
$30.31 |
| 84460 |
|
16 |
12 |
$26.60 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
32 |
30 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
98 |
97 |
$0.00 |